biocon
Biocon Biologicsā CEO reveals pricing strategy and device design for Hulio, its Humira biosimilar, in the US market
Anika Sharma
The competition in the biosimilar arena targeting AbbVie’s blockbuster drug Humira, also known as adalimumab, is heating up. However, for ...
Biocon appoints Peter Bains as group CEO to lead its global expansion
Anika Sharma
Biocon has appointed Peter Bains as its new CEO as the company seeks to expand its presence in North America ...